AURA - Aura Biosciences Inc Company Long-Term Liabilities

Public company logo of Aura Biosciences Inc (AURA)

This price chart on the GURU.Markets platform demonstrates the price action of Aura Biosciences, Inc. (AURA), which integrates ESG principles into tumor combat by strictly controlling waste disposal. Business development relies on the results of eye cancer treatment trials and regulatory approvals. The current individual long-term debt figure stands at 0.01, while the company remains pre-revenue, awaiting commercial recognition of its developments.

aurabiosciences.com (AURA) Company Long-Term Debt: for the period 07/04/2022 - 11/01/2026

Aura Bio (AURA) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price aurabiosciences.com|AURA - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation Aura Biosciences|AURA - Enterprise Value
- shareholders' equity book value data:
Net Asset Value per Share Aura Biosciences|AURA - Company Book Value|Market Value to Book Value aurabiosciences.com|AURA - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Aura Biosciences, Inc.|AURA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Aura Corp|AURA - Company Total Debt|Debts to Book Capitalization Aura Biosciences|AURA - Company Long-Term Debt|Company Short-Term Loans and Borrowings Aura Biosciences|Immediate Liquidity aurabiosciences.com
- earnings and market multiples details:
AURA - Net Profit
Fundamental company valuation:AURA (aurabiosciences.com)
Brand item of Aura Biosciences, Inc.

Long-term debt measures the total volume of obligations with a maturity exceeding twelve months. Daily monitoring allows for an assessment of financial stability trends prior to the publication of official financial statements. By analyzing the trajectory of a company's long-term debt, an investor can distinguish critical leverage from strategic financing. For Aura Biosciences, Inc. (AURA), such funds may be directed toward implementing strict ESG standards for bio-waste disposal in oncology research.

Competitors of Aura Biosciences, Inc. (AURA)

ONC: Company Long-Term Indebtedness|Halozyme - Company Long-Term Debts|Revolution Medicines Inc (RVMD) - Company Long-Term Liabilities|AAPG: Company Long-Term Debts|Long-Term Debt CG Oncology Therapeutics (CGON)|Company Long-Term Debt UroGen Pharma Ltd.|BCAX: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities PSNL (Personalis)|ERAS (Erasca Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts DCTH (Delcath)|YMAB - Company Long-Term Liabilities|CADL: Company Long-Term Liabilities|ARAY - Company Long-Term Debts|sellaslifesciences.com (SLS) - Company Long-Term Debt|Actuate Therapeutics Inc. - Company Long-Term Loans and Borrowings|CTOR (Citius Oncology, Inc) - Company Long-Term Debts|Long-Term Debt TuHURA HURA|Company Long-Term Debts TARA|Company Long-Term Debts fatetherapeutics.com (FATE)|Aadi Bioscience - Company Long-Term Liabilities|Company Long-Term Debts TScan Therapeutics Inc TCRX|CSBR - Company Long-Term Debt|Company Long-Term Loans and Borrowings XBIT (XBiotech Inc.)|CVM: Company Long-Term Debts|ostherapies.com (OSTX) - Company Long-Term Debts|Company Long-Term Liabilities RADX|ARTV: Company Long-Term Loans and Borrowings|Company Long-Term Debts ANL|Company Long-Term Debt VERU (Veru Corporation)|Company Long-Term Debts TPST (Tempest Therapeutics)|Long-Term Debt Volume Xilio Therapeutics Inc (XLO)|RENB - Company Long-Term Debt|Long-Term Debt Mural Oncology plc|kairospharma.com (KAPA) - Company Long-Term Debt|OKUR - Long-Term Debt Volume|GDTC (CytoMed Therapeutics Ltd) - Company Long-Term Debts|Company Long-Term Liabilities Curis Corp (CRIS)|Company Long-Term Debts APLM|Long-Term Debt Volume Tharimmune Inc|Company Long-Term Debts ADVB (Advanced Biomed)|Genprex Inc (GNPX) - Long-Term Debt|CLDI - Company Long-Term Debt|SBFM (Sunshine Biopharma Inc.) - Company Long-Term Indebtedness|XBIO: Company Long-Term Debts|Company Long-Term Liabilities Salarius Pharmaceuticals Inc|PPBT (Purple Biotech Corp) - Company Long-Term Debts|Long-Term Debt AON AONC|Company Long-Term Debt BeiGene, Ltd. (BGNE)|Long-Term Debt Volume checkpointtx.com|Elevation Oncology, Inc. - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings ICAD|Ikena - Company Long-Term Debts|Long-Term Debt Volume Notable Labs Corp NTBL|viracta.com (VIRX) - Company Long-Term Debt|Company Long-Term Indebtedness MOR|NAYA (NAYA Biosciences Inc.) - Company Long-Term Debts|Company Long-Term Liabilities Ascentage Pharma Group International (AAPGV)